
News, Articles & Press Releases
-
August 28, 2023
Cellares Announces Bristol Myers Squibb has Joined Technology Adoption Partnership Program to Evaluate Automated Manufacturing of CAR-T Cell Therapy on the Cell Shuttle Platform
-
August 23, 2023
Exclusive: Bloomberg Technology’s Ed Ludlow Interviews Cellares’ CEO and Co-founder, Fabian Gerlinghaus on Company’s Massive $255M Series C Up-Round
-
August 23, 2023
Fabian Gerlinghaus, Cellares CEO & Co-Founder, Unveils the Launch of the World’s First Integrated Development and Manufacturing Organization (IDMO) and Pioneering Smart Factory to Meet Global Demand for Life-Saving Cell Therapies
-
August 23, 2023
Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization (IDMO) and Pioneering Smart Factory to Meet Global Demand for Life-Saving Cell Therapies
-
April 12, 2023
Cellares Hires Former Novartis Executive and Bristol-Myers Squibb Alum to Lead Commercialization
-
January 18, 2023
As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing
-
January 11, 2023
Automated Manufacturing Will Deliver More—and Better—Cell Therapies
-
November 14, 2022
Business Insider
-
November 14, 2022
Einav Kraft recognized on Healthcare Technology Report’s The Top 25 Women Leaders in Biotechnology 2022 list.
-
October 06, 2022
Will Manufacturing Be the Stumbling Block for T-Cell Therapies?
-
September 20, 2022
Cellares to tackle key roadblock in cell therapy manufacturing with new partner iVexSol
-
May 04, 2022
Fabian Gerlinghaus recognized in Medicine Maker Power List 2022
-
April 26, 2022
Drug Discovery & Development
-
November 16, 2021
Cellares Appoints Ezekiel Emanuel to Board of Advisors
-
November 11, 2021
Biotech Companies are Expanding the Frontiers of Engineered Cell Therapy
-
October 27, 2021
Fabian Gerlinghaus receives 2021 Life Science Catalyst Award
-
October 11, 2021
Cellares Appoints John Tomtishen as Vice President of Operations
-
July 28, 2021
Forbes
-
July 14, 2021
Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy
-
July 14, 2021
Fierce Pharma
-
July 14, 2021
GeneOnline
-
July 14, 2021
Drug Discovery & Development
-
July 14, 2021
Endpoints
-
July 14, 2021
BioProcess International
-
May 06, 2021
Fierce Pharma
-
May 05, 2021
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing
-
May 05, 2021
Reuters
-
May 05, 2021
Endpoints
-
May 05, 2021
Crunchbase
-
May 05, 2021
MedCity News
-
April 26, 2021
BioProcess International
-
April 15, 2021
Fabian Gerlinghaus featured in Medicine Maker Power List 2021
-
February 11, 2021
Cellares Appoints Dr. Rodney L. Rietze to Advisory Board
-
February 08, 2021
CAR-T Sector Seeks Tech Boost to Meet Anticipated Demand
-
January 25, 2021
Spearheading a Paradigm Shift in Cell Therapy Manufacturing
-
January 08, 2021
Cellares Adds PACT Pharma to its Early Access Partnership Program
-
December 02, 2020
Einav Kraft joins Cellares as Vice President of Quality
-
October 29, 2020
Cellares Welcomes Fred Hutchinson Cancer Research Center Into Its Early Access Partnership Program
-
October 29, 2020
Cellares – Evolving the Pharmaceutical Manufacturing Industry
Media Kit